Abstract:Background: Diseases of the nervous system are widely considered to be caused by genetic mutations, and they have been shown to share pathogenic genes. Discovering the shared mechanisms of these diseases is useful for designing common treatments. Method: In this study, by reviewing 518 articles published after 2007 on 20 diseases of the nervous system, we compiled data on 1607 mutations occurring in 365 genes, totals that are 1.9 and 3.2 times larger than those collected in the Clinvar database, respectively. A combination with the Clinvar data gives 2434 pathogenic mutations and 424 genes. Using this information, we measured the genetic similarities between the diseases according to the number of genes causing two diseases simultaneously. Further detection was carried out on the similarity between diseases in terms of cell types. Disease-related cell types were defined as those with disease-related gene enrichment among the marker genes of cells, as ascertained by analyzing single-cell sequencing data. Enrichment profiles of the disease-related genes over 25 cell types were constructed. The disease similarity in terms of cell types was obtained by calculating the distances between the enrichment profiles of these genes. The same strategy was applied to measure the disease similarity in terms of brain regions by analyzing the gene expression data from 10 brain regions. Results: The disease similarity was first measured in terms of genes. The result indicated that the proportions of overlapped genes between diseases were significantly correlated to the DMN scores (phenotypic similarity), with a Pearson correlation coefficient of 0.40 and P-value = 6.0×10-3. The disease similarity analysis for cell types identified that the distances between enrichment profiles of the disease-related genes were negatively correlated to the DMN scores, with Spearman correlation coefficient = -0.26 (P-value = 1.5 × 10-2). However, the brain region enrichment profile distances of the disease-related genes were not significantly correlated with the DMN score. Besides the similarity of diseases, this study identified novel relationships between diseases and cell types. Conclusion: We manually constructed the most comprehensive dataset to date for genes with mutations related to 20 nervous system diseases. By using this dataset, the similarities between diseases in terms of genes and cell types were found to be significantly correlated to their phenotypic similarity. However, the disease similarities in terms of brain regions were not significantly correlated with the phenotypic similarities. Thus, the phenotypic similarity between the diseases is more likely to be caused by dysfunctions of the same genes or the same types of neurons rather than the same brain regions. The data are collected into the database NeurodisM, which is available at http://biomed-ai.org/neurodism.

Quantitative Mapping of Genetic Similarity in Human Heritable Diseases by Shared Mutations

Towards Prediction and Prioritization of Disease Genes by the Modularity of Human Phenome-Genome Assembled Network.

Identifying Common Genes, Cell Types and Brain Regions Between Diseases of the Nervous System

A Disease Similarity Matrix Based on the Uniqueness of Shared Genes

Sharing of Genes and Pathways Across Complex Phenotypes: A Multilevel Genome-Wide Analysis.

Novel Association Strategy with Copy Number Variation for Identifying New Risk Loci of Human Diseases

The High-Dimensional Space of Human Diseases Built from Diagnosis Records and Mapped to Genetic Loci

A Computational Method Based On The Integration Of Heterogeneous Networks For Predicting Disease-Gene Associations

Disease Gene Discovery of Single-Gene Disorders Based on Complex Network

Comparative Study of Network-Based Prioritization of Protein Domains Associated with Human Complex Diseases

Analysis of shared heritability in common disorders of the brain

Investigating the shared genetic architecture between breast and ovarian cancers

Mapping the proteo-genomic convergence of human diseases

Polygenicity and Prevalence Contribute to Investigating the Genetic Signature of Common Diseases

Chromatin interactions and expression quantitative trait loci reveal genetic drivers of multimorbidities

Quantifying concordant genetic effects of de novo mutations on multiple disorders

Identifying the genetic basis and molecular mechanisms underlying phenotypic correlation between complex human traits using a gene-based approach

Inferring the Genetic Relationship Between Brain Imaging-Derived Phenotypes and Risk of Complex Diseases by Mendelian Randomization and Genome-Wide Colocalization.

Align Human Interactome with Phenome to Identify Causative Genes and Networks Underlying Disease Families.

Investigating the common genetic architecture and causality of metabolic disorders with neurodegenerative diseases

Shared molecular mechanisms and transdiagnostic potential of neurodevelopmental disorders and immune disorders